CCL3L1 copy number variation and susceptibility to HIV-1 infection: A meta-analysis

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Liu, SiJie ^a   Yao, Lei ^a   Ding, DongLin ^a   Zhu, HuanZhang ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; BETA CHEMOKINE; CCL3L1 PROTEIN, HUMAN;

ADULT; AGE DISTRIBUTION; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; COPY NUMBER VARIATION; ETHNICITY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MODEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION RISK; INFECTION SENSITIVITY; META ANALYSIS (TOPIC); PROTEIN FUNCTION; SAMPLE SIZE; COHORT ANALYSIS; GENE DOSAGE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS 1; META ANALYSIS; METABOLISM; PHYSIOLOGY; RISK;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ADULT; CASE-CONTROL STUDIES; CHEMOKINE CCL3; CHEMOKINES, CC; COHORT STUDIES; DNA COPY NUMBER VARIATIONS; GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; ODDS RATIO;

EID: 78651239869     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015778     Document Type: Article

References (40)

1. Epidemiology of AIDS. Death toll of AIDS has exceeded the first world war. Available at: http://aids.39.net/ka/091/31/780270. Accessed 31 January 2009.
2. Kaslow RA, Dorak T, Tang JJ (2005) Influence of host genetic variation on susceptibility to HIV type 1 infection. J Infect Dis 191: 568-572.
3. Telenti A, Goldstein DB (2006) Genomics meets HIV. Nat Rev Microbiol 4: 9-18.
4. NCBI - Entrez Gene. CCL3L1 chemokine (C-C motif) ligand 3-like 1. Available at: http://www.ncbi.nlm.nih.gov/gene/6349. Accessed 29 May 2010.
5. Arenzana-Seisdedos F, Parmentier M (2006) Genetics of resistance to HIV infection: role of co-receptors and co-receptor ligands. Semin Immunol 18: 387-403.
6. Nakajima T, Kaur G, Mehra N, Kimura A (2008) HIV/AIDS susceptibility and copy number variation in CCL3L1, a gene encoding a natural ligand for HIV-1 co-receptor CCR5. Cytogenet Genome Res 123: 156-160.
7. Kuhn L, Schramm DB, Donninger S, Meddows-Taylor S, Coovadia AH, et al. (2007) African infants' CCL3 gene copies influence perinatal HIV transmission in the absence of maternal nevirapine. AIDS 21: 1753-1761.
8. Meddows-Taylor S, Donninger SL, Paximadis M, Schramm DB, Anthony FS, et al. (2006) Reduced ability of newborns to produce CCL3 is associated with increased susceptibility to perinatal human immunodeficiency virus 1 transmission. J Gen Virol 87: 2055-2065.
9. Shostakovich-Koretskaya L, Catano G, Chykarenko ZA, He W, Gornalusse G, et al. (2009) Combinatorial content of CCL3L and CCL4L gene copy numbers influence HIV-AIDS susceptibility in Ukrainian children. AIDS 23: 679-688.
10. Gonzalez E, Kulkarni H, Bolivar H, Mangano A, Sanchez R, et al. (2005) The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 307: 1434-1440.
11. Nakajima T, Ohtani H, Naruse T, Shibata H, Mimaya JI, et al. (2007) Copy number variations of CCL3L1 and long-term prognosis of HIV-1 infection in asymptomatic HIV-infected Japanese with hemophilia. Immunogenetics 59: 793-798.
12. Huik K, Sadam M, Karki T, Avi R, Krispin T, et al. (2010) CCL3L1 Copy Number Is a Strong Genetic Determinant of HIV Seropositivity in Caucasian Intravenous Drug Users. JID 201: 730-739.
13. Urban TJ, Weintrob AC, Fellay J, Colombo S, Shianna KV, et al. (2009) CCL3L1 and HIV/AIDS susceptibility. Nat Med 15: 1009-1110.
14. Bhattacharya T, Stanton J, Kim EY, Kunstman KJ, Phair JP, et al. (2009) CCL3L1 and HIV/AIDS susceptibility. Nat Med 15: 1112-1115.
15. Shao W, Tang J, Song W, Wang C, Li Y, et al. (2007) CCL3L1 and CCL4L1: variable gene copy number in adolescents with and without human immunodeficiency virus type 1 (HIV-1) infection. Genes and Immunity 8: 224-231.
16. Rathore A, Chatterjee A, Sivarama P, Yamamoto N, Singhal PK, et al. (2009) Association of CCR5-59029 A/G and CCL3L1 Copy Number Polymorphism with HIV Type 1 Transmission/Progression among HIV Type 1-Seropositive and Repeatedly Sexually Exposed HIV Type 1-Seronegative North Indians. AIDS Research and Human Retroviruses 25: 1149-1156.
17. Cochran W G (1954) The combination of estimates from different experiments. Biometrics: 10: 29.
18. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Nat Cancer Inst 22: 719-748.
19. Dersimonian R, Larid N (1986) Mata-analysis in clinical trials. Control Clin Trials 7: 177-188.
20. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
21. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1100.
22. Tobias A (1999) Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull 8.
23. Bugeja MJ, Booth DR, Bennetts BH, Guerin J, Kaldor JM, et al. (2004) Analysis of the CCL3-L1 gene for association with HIV-1 susceptibility and disease progression. AIDS 18: 1069-1071.
24. Mackay CR (2005) CCL3L1 dose and HIV-1 susceptibility. TRENDS in Molecular Medicine; 11: 203-206.
25. Kulkarni H, Agan BK, Marconi VC, O'Connell RJ, Camargo JF, et al. (2008) CCL3L1-CCR5 Genotype Improves the Assessment of AIDS Risk in HIV-1- Infected Individuals. PLoS ONE 3: e3165.
26. Degenhardt JD, de Candia P, Chabot A, Schwartz S, Henderson L, et al. (2009) Copy Number Variation of CCL3-like Genes Affects Rate of Progression to Simian- AIDS in Rhesus Macaques (Macaca mulatta). PLoS Genetics 5: e1000346.
27. Gonzalez E, Dhanda R, Bamshad M, Mummidi S, Geevarghese R, et al. (2001) Global survey of genetic variation in CCR5, RANTES, and MIP-1a: Impact on the epidemiology of the HIV-1 pandemic. PNAS 98: 5199-5204.
28. Moore JP, Klasse PJ (2007) HIV-1 Pathogenesis: The Complexities of the CCR5-CCL3L1 Complex. Cell Host & Microbe 2: 281-283.
29. Shalekoff S, Meddows-Taylor S, Schramm DB, Donninger SL, Gray GE, et al. (2008) Host CCL3L1 Gene Copy Number in Relation to HIV-1-Specific CD4+ and CD8+ T-Cell Responses and Viral Load in South African Women. J Acquir Immune Defic Syndr 48: 245-254.
30. Jülg B, Goebel FD (2005) Susceptibility to HIV/AIDS: An Individual Characteristic We Can Measure? Infection 33: 160-162.
31. Modi WS, Lautenberger J, An P, Scott K, Goedert JJ, et al. (2006) Genetic Variation in the CCL18-CCL3-CCL4 Chemokine Gene Cluster Influences HIV Type 1 Transmission and AIDS Disease Progression. The American Journal of Human Genetics 79: 120-128.
32. Kaur G, Mehra N (2009) Genetic determinants of HIV-1 infection and progression to AIDS: susceptibility to HIV infection. John Wiley & Sons A/STissue Antigens 73: 289-301.
33. Ioannidis JP, Rosenberg PS, Goedert JJ, O'Brien TR (2002) Meta-analysis of individual participants' data in genetic epidemiology. Am J Epidemiol 156: 204-210.
34. He W, Kulkarni H, Castiblanco J, Shimizu C, Aluyen U, et al. (2009) Reply to: "Experimental aspects of copy number variant assays at CCL3L1". Nat Med 15: 1117-1120.
35. Dolan MJ, Kulkarni H, Camargo JF, He W, Smith A, et al. (2007) CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms. Nat Immunol 8: 1324-1336.
36. Ioannidis JP (2002) Genetic associations: false or true? Trends Mol Med 2003 9: 135-138.
37. Hirschorn JN, Lohmueller K, Byrne E, Hirschorn K (2002) A comprehensive review of genetic association studies. Genet Med 4: 45-61.
38. Wacholder S, Chanok S, Garcia-Closas M, EI Ghormli L, Rothman N (2004) Accessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96: 434-442.
39. Shrestha S, Tang J, Kaslow RA (2009) Gene copy number: learning to count past two. Nat Med 15: 1127-1129.
40. Colobran R, Pedrosa E, Carretero-lglesia L, Juan M (2010) Copy number variation in chemokine superfamily: the complex scene of CCL3L-CCL4L genes in health and disease. Clin Exp Immunol 162: 41-52.